Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
INOV has been steadily improving UAFRS-based (Uniform) ROA the past few years before the pandemic, thanks to its conversion from a dataset company to a healthcare insight software platform with significant growth opportunities. And yet the market doesn't recognize how this can continue to mean accelerating returns and growth going forward. While the company has one of the few leading healthcare insight platforms not already captured by a major player like UnitedHealthcare, and currently only...
Sonos, Inc. (SONO:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 31.8x Uniform P/E, implying bullish expectations for the firm. Meanwhile, although management may have concerns about DTC demand, marketing investments, and margins, market expectations are still too pessimistic, suggesting long-term equity outperformance remains warranted Specifically, management may be overstating the sustainability of demand for their direct-to-consumer (DTC) p...
KEYS has seen strong improvement in UAFRS-based (Uniform) ROA the past few years, thanks to its strong legacy business and growth into a high return SaaS business model. While the market is pricing the company for returns and growth to stagnate going forward, there is no reason returns cannot continue to accelerate. The company is likely to see returns stay flat at worst with steady growth, thanks to its position as the market leader in the circuit testing and design business, a growing market ...
Sonos, Inc. (SONO:USA) currently trades near corporate averages relative to UAFRS-based (Uniform) earnings, with a 21.0x Uniform P/E. At these levels, the market has bullish expectations for the firm. However, although management may have concerns about margin growth, R&D investments, and supply chain constraints, market expectations are still too bearish, suggesting equity outperformance remains warranted Specifically, management may lack confidence in their ability to sustain margin growth an...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.